These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Liposome-encapsulated ciprofloxacin is effective in the protection and treatment of BALB/c mice against Francisella tularensis. Di Ninno VL; Cherwanogrodzky JW; Wong JP J Infect Dis; 1993 Sep; 168(3):793-4. PubMed ID: 8354928 [No Abstract] [Full Text] [Related]
5. The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy. Hamblin KA; Wong JP; Blanchard JD; Atkins HS Front Cell Infect Microbiol; 2014; 4():79. PubMed ID: 24995163 [TBL] [Abstract][Full Text] [Related]
6. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259 [TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice. Piercy T; Steward J; Lever MS; Brooks TJ J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941 [TBL] [Abstract][Full Text] [Related]
9. [The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia]. D'iakov SI; Bubnov VP; Lebedeva IK; Sidorenko SV; Moskalenko VI Antibiot Khimioter; 2000; 45(6):17-20. PubMed ID: 10904804 [TBL] [Abstract][Full Text] [Related]
10. Synthetic Macromolecular Antibiotic Platform for Inhalable Therapy against Aerosolized Intracellular Alveolar Infections. Das D; Chen J; Srinivasan S; Kelly AM; Lee B; Son HN; Radella F; West TE; Ratner DM; Convertine AJ; Skerrett SJ; Stayton PS Mol Pharm; 2017 Jun; 14(6):1988-1997. PubMed ID: 28394614 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia. Russell P; Eley SM; Fulop MJ; Bell DL; Titball RW J Antimicrob Chemother; 1998 Apr; 41(4):461-5. PubMed ID: 9598777 [TBL] [Abstract][Full Text] [Related]
12. Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections. Su FY; Srinivasan S; Lee B; Chen J; Convertine AJ; West TE; Ratner DM; Skerrett SJ; Stayton PS J Control Release; 2018 Oct; 287():1-11. PubMed ID: 30099019 [TBL] [Abstract][Full Text] [Related]
13. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R; Harris G; Conlan JW; Chen W Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863 [TBL] [Abstract][Full Text] [Related]
14. Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection. Rotem S; Bar-Haim E; Cohen H; Elia U; Ber R; Shafferman A; Cohen O Antimicrob Agents Chemother; 2012 Oct; 56(10):5406-8. PubMed ID: 22850512 [TBL] [Abstract][Full Text] [Related]
16. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism. Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834 [TBL] [Abstract][Full Text] [Related]
17. Effects of liposome-encapsulated ciprofloxacin on phagocytosis, nitric oxide and intracellular killing of Staphylcoccus aureus by murine macrophages. Wong JP; Schnell G; Simpson M; Saravolac E Artif Cells Blood Substit Immobil Biotechnol; 2000 Sep; 28(5):415-28. PubMed ID: 11009114 [TBL] [Abstract][Full Text] [Related]
18. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques. Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261 [TBL] [Abstract][Full Text] [Related]
19. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Oh YK; Nix DE; Straubinger RM Antimicrob Agents Chemother; 1995 Sep; 39(9):2104-11. PubMed ID: 8540724 [TBL] [Abstract][Full Text] [Related]